Sarepta Gene Therapy Win Helps to Validate Broader Platform

(Bloomberg) -- Data on Sarepta Therapeutics Inc.’s experimental gene therapy for a rare type of muscular dystrophy showed that patients receiving a higher dose of the medicine saw greater benefits ...